SCLX
Price
$6.35
Change
-$0.01 (-0.16%)
Updated
Jul 7, 01:16 PM (EDT)
Capitalization
165.55M
VRBCF
Price
$346.00
Change
+$22.00 (+6.79%)
Updated
May 22 closing price
Capitalization
2.61B
Interact to see
Advertisement

SCLX vs VRBCF

Header iconSCLX vs VRBCF Comparison
Open Charts SCLX vs VRBCFBanner chart's image
Scilex Holding
Price$6.35
Change-$0.01 (-0.16%)
Volume$700
Capitalization165.55M
Virbac SA
Price$346.00
Change+$22.00 (+6.79%)
Volume$23
Capitalization2.61B
SCLX vs VRBCF Comparison Chart in %
Loading...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SCLX vs. VRBCF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCLX is a Hold and VRBCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (SCLX: $6.36 vs. VRBCF: $346.00)
Brand notoriety: SCLX and VRBCF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: SCLX: 18% vs. VRBCF: 135%
Market capitalization -- SCLX: $165.55M vs. VRBCF: $2.61B
SCLX [@Pharmaceuticals: Major] is valued at $165.55M. VRBCF’s [@Pharmaceuticals: Major] market capitalization is $2.61B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCLX’s FA Score shows that 0 FA rating(s) are green whileVRBCF’s FA Score has 0 green FA rating(s).

  • SCLX’s FA Score: 0 green, 5 red.
  • VRBCF’s FA Score: 0 green, 5 red.
According to our system of comparison, VRBCF is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCLX’s TA Score shows that 6 TA indicator(s) are bullish while VRBCF’s TA Score has 2 bullish TA indicator(s).

  • SCLX’s TA Score: 6 bullish, 4 bearish.
  • VRBCF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, SCLX is a better buy in the short-term than VRBCF.

Price Growth

SCLX (@Pharmaceuticals: Major) experienced а +20.00% price change this week, while VRBCF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.86%. For the same industry, the average monthly price growth was +0.39%, and the average quarterly price growth was +8.84%.

Industries' Descriptions

@Pharmaceuticals: Major (+0.86% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRBCF($2.61B) has a higher market cap than SCLX($166M). VRBCF YTD gains are higher at: 1.996 vs. SCLX (-57.384). VRBCF has higher annual earnings (EBITDA): 213M vs. SCLX (-109.1M). VRBCF has more cash in the bank: 176M vs. SCLX (3.92M). SCLX has less debt than VRBCF: SCLX (128M) vs VRBCF (148M). VRBCF has higher revenues than SCLX: VRBCF (1.15B) vs SCLX (46.7M).
SCLXVRBCFSCLX / VRBCF
Capitalization166M2.61B6%
EBITDA-109.1M213M-51%
Gain YTD-57.3841.996-2,875%
P/E RatioN/A29.33-
Revenue46.7M1.15B4%
Total Cash3.92M176M2%
Total Debt128M148M86%
FUNDAMENTALS RATINGS
VRBCF: Fundamental Ratings
VRBCF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
54
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SCLXVRBCF
RSI
ODDS (%)
Bearish Trend 5 days ago
39%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
47%
Bullish Trend 5 days ago
36%
Momentum
ODDS (%)
Bullish Trend 5 days ago
41%
N/A
MACD
ODDS (%)
Bullish Trend 5 days ago
44%
Bearish Trend 5 days ago
25%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
44%
Bullish Trend 5 days ago
16%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
32%
Bullish Trend 5 days ago
17%
Advances
ODDS (%)
Bullish Trend 5 days ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
42%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
27%
Bullish Trend 5 days ago
11%
View a ticker or compare two or three
Interact to see
Advertisement
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYVYX607.6011.57
+1.94%
Rydex NASDAQ-100® 2x Strategy H
FGSAX64.100.72
+1.14%
Federated Hermes MDT Mid Cap Growth A
RMBHX36.070.35
+0.98%
RMB A
WPOPX13.820.10
+0.73%
Weitz Partners III Opportunity Instl
VSMAX116.630.83
+0.72%
Vanguard Small Cap Index Admiral Shares

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and CSWYF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and CSWYF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
+1.92%
CSWYF - SCLX
24%
Poorly correlated
N/A
BIIB - SCLX
23%
Poorly correlated
-0.24%
AMRN - SCLX
21%
Poorly correlated
+0.48%
PFE - SCLX
18%
Poorly correlated
+0.24%
ABBV - SCLX
13%
Poorly correlated
-0.77%
More

VRBCF and

Correlation & Price change

A.I.dvisor tells us that VRBCF and SCLX have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VRBCF and SCLX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRBCF
1D Price
Change %
VRBCF100%
N/A
SCLX - VRBCF
9%
Poorly correlated
+1.92%
MIRA - VRBCF
4%
Poorly correlated
-3.23%
CSWYF - VRBCF
0%
Poorly correlated
N/A
JCRRF - VRBCF
-0%
Poorly correlated
N/A
SNYNF - VRBCF
-0%
Poorly correlated
+1.74%
More